+373 (22) 870-971

Contul meu
Ofertă pentruDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg
Date procedură de achiziție
ID procedură
ocds-b3wdp1-MD-1732642177049-EV-1732642516428
Titlu
Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2025 (repetat nr. 1)
Beneficiar
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
Descriere
Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2025 (repetat nr. 1)
Valoare achiziție
8,846,119.14 MDL
Perioadă de depunere oferte
2024-12-06 08:00:00 - 2024-12-12 11:00:00
Ofertă
Lot
Obiect achiziție
Valoare lot
Valuta
Valoare ofertă, fără TVA
Dolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg
Dolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg
Publicată la data: 12/12/2024 10:29
Documente
DataNumeTipReferințaDescriereLimba
16/12/2024 09:1970licentasigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg70licentasigned.pdfRomana
16/12/2024 09:1980certificatdeinregistraresigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg80certificatdeinregistraresigned.pdfRomana
16/12/2024 09:1990extrasdinregistrusigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg90extrasdinregistrusigned.pdfRomana
16/12/2024 09:19100sf2023signed.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg100sf2023signed.pdfRomana
16/12/2024 09:19110listafondatorilorsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg110listafondatorilorsigned.pdfRomana
16/12/2024 09:1910cereredeparticiparesigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg10cereredeparticiparesigned.pdfRomana
16/12/2024 09:1920declaratieprivindvalabilitateaoferteisigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg20declaratieprivindvalabilitateaoferteisigned.pdfRomana
16/12/2024 09:1940propunereatehnicăsigned.pdfPropunere tehnicăDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg40propunereatehnicăsigned.pdfRomana
16/12/2024 09:1950propunereafinanciarăsigned.pdfPropunere financiarăDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg50propunereafinanciarăsigned.pdfRomana
16/12/2024 09:19120certificatprivindlipsarestantelor-1054740signed.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg120certificatprivindlipsarestantelor-1054740signed.pdfRomana
16/12/2024 09:19130certificatmaibsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg130certificatmaibsigned.pdfRomana
16/12/2024 09:19140declaratietermen_signedsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg140declaratietermen_signedsigned.pdfRomana
16/12/2024 09:19100sf2023signed.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg100sf2023signed.pdfRomana
16/12/2024 09:1910cereredeparticiparesigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg10cereredeparticiparesigned.pdfRomana
16/12/2024 09:1920declaratieprivindvalabilitateaoferteisigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg20declaratieprivindvalabilitateaoferteisigned.pdfRomana
16/12/2024 09:1940propunereatehnicăsigned.pdfPropunere tehnicăDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg40propunereatehnicăsigned.pdfRomana
16/12/2024 09:1950propunereafinanciarăsigned.pdfPropunere financiarăDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg50propunereafinanciarăsigned.pdfRomana
16/12/2024 09:1970licentasigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg70licentasigned.pdfRomana
16/12/2024 09:1980certificatdeinregistraresigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg80certificatdeinregistraresigned.pdfRomana
16/12/2024 09:1990extrasdinregistrusigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg90extrasdinregistrusigned.pdfRomana
16/12/2024 09:19110listafondatorilorsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg110listafondatorilorsigned.pdfRomana
16/12/2024 09:19120certificatprivindlipsarestantelor-1054740signed.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg120certificatprivindlipsarestantelor-1054740signed.pdfRomana
16/12/2024 09:19130certificatmaibsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg130certificatmaibsigned.pdfRomana
16/12/2024 09:19140declaratietermen_signedsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg140declaratietermen_signedsigned.pdfRomana
16/12/2024 09:19confirmationofsubmissionspegrasigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mgconfirmationofsubmissionspegrasigned.pdfRomana
16/12/2024 09:19spegra_commonsigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mgspegra_commonsigned.pdfRomana
16/12/2024 09:19eugmpemcuresigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mgeugmpemcuresigned.pdfRomana
16/12/2024 09:19whogmpcerthinjawadisigned.pdfDoc. de calificareDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mgwhogmpcerthinjawadisigned.pdfRomana
13/12/2024 13:3330gbsignedsigned.pdfGaranțiiDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg30gbsignedsigned.pdfRomana
13/12/2024 13:3360duaesigned.pdfDoc. de eligibilitate (DUAE)Dolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg60duaesigned.pdfRomana
13/12/2024 13:3330gbsignedsigned.pdfGaranțiiDolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg30gbsignedsigned.pdfRomana
13/12/2024 13:3360duaesigned.pdfDoc. de eligibilitate (DUAE)Dolutegravirum+ Emtricitabinum+ Tenofovirium alafenamidum 50 mg+200 mg+25 mg60duaesigned.pdfRomana